Eli Lilly and Company News - February 4, 2026
🟢 LLY is trading 9.42% up today after Q4 earnings beat and strong FY2026 guidance
LLY is trading at $1097.95 (+9.42%) following a Q4 2025 earnings beat driven by a 43% surge in revenue to $19.3 billion, fueled by massive demand for Mounjaro...
Eli Lilly's fourth quarter 2025 revenue surged 43% to $19.3 billion, driven by blockbuster sales of Mounjaro and Zepbound.
Eli Lilly reported fourth quarter 2025 revenue of $19.3 billion, a 43% increase year-over-year, driven by strong volume growth. Non-GAAP earnings per share...
Eli Lilly Surges 7% Pre-Market on Tirzepatide Optimism and 31% EPS Growth Forecast
Eli Lilly shares rose 7.18% in pre-market trading on February 4, 2026. The stock reached a price of $1075.49. This follows a close of $1003.46 on February 3....